Nitric oxide positively regulates Ag (I)-induced Ca2+ influx and mast cell activation: Role of a nitric oxide synthase-independent pathway

Journal of Leukocyte Biology

Volumn 86, Issue 6, 2009, Pages 1365-1375

  Inoue, Toshio ^a   Suzuki, Yoshihiro ^a   Yoshimaru, Tetsuro ^a,b   Ra, Chisei ^a  

^a NIHON UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Ca2+ channel; Silver

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL; DITHIOTHREITOL; HEMOGLOBIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; SILVER; WORTMANNIN;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL ACTIVATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME RELEASE; EXTRACELLULAR FLUID; GENE SILENCING; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANDROSTADIENES; ANIMALS; BETA-N-ACETYLHEXOSAMINIDASES; CALCIUM; CALCIUM CHANNELS, L-TYPE; CELL DEGRANULATION; CELL LINE; DITHIOTHREITOL; ENZYME INHIBITORS; HEMOGLOBINS; HUMANS; LEUKOTRIENE C4; MAST CELLS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SILVER;

EID: 73149087490     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0609387     Document Type: Article

References (54)

1. Grisham, M. B., Jourd'Heuil, D., Wink, D. A. (1999) Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am. J. Physiol. 276, G315-G321.
2. Coleman, J. W. (2002) Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation. Clin. Exp. Immunol. 129, 4 -10.
3. Eastmond, N. C., Banks, E. M., Coleman, J. W. (1997) Nitric oxide inhibits IgE-mediated degranulation of mast cells and is the principal intermediate in IFN-γ-induced suppression of exocytosis. J. Immunol. 159, 1444-1450.
4. Davis, B. J., Flanagan, B. F., Gilfillan, A. M., Metcalfe, D. D., Coleman, J. W. (2004) Nitric oxide inhibits IgE-dependent cytokine production and Fos and Jun activation in mast cells. J. Immunol. 173, 6914-6920.
5. Sekar, Y., Moon, T. C., Muñoz, S., Befus, A. D. (2005) Role of nitric oxide in mast cells. Immunol. Res. 33, 223-229.
6. Gilchrist, M., Savoie, M., Nohara, O., Wills, F. L., Wallace, J. L., Befus, A. D. (2002) Nitric oxide synthase and nitric oxide production in vivo-derived mast cells. J. Leukoc. Biol. 71, 618-624.
7. Gilchrist, M., McCauley, S. D., Befus, A. D. (2004) Expression, localization, and regulation of NOS in human mast cell lines: effects on leukotriene production. Blood 104, 462-469.
8. Inoue, T., Suzuki, Y., Yoshimaru, T., Ra, C. (2008) Nitric oxide protects mast cells from activation-induced cell death: the role of the phosphatidylinositol-3 kinase-Akt-endothelial nitric oxide synthase pathway. J. Leukoc. Biol. 83, 1218-1229.
9. Druet, E., Sapin, C., Günther, E., Feingold, N., Druet, P. (1977) Mercuric chloride-induced anti-glomerular basement membrane antibodies in the rat: genetic control. Eur. J. Immunol. 7, 348-351.
10. Monestier, M., Losman, M. J., Novick, K. E., Aris, J. P. (1994) Molecular analysis of mercury-induced antinucleolar antibodies in H-2S mice. J. Immunol. 152, 667-675.
11. Hultman, P., Eneström, S., Turley, S. J., Pollard, K. M. (1994) Selective induction of anti-fibrillarin autoantibodies by silver nitrate in mice. Clin. Exp. Immunol. 96, 285-291.
12. Hultman, P., Ganowiak, K., Turley, S. J., Pollard, K. M. (1995) Genetic susceptibility to silver-induced anti-fibrillarin autoantibodies in mice. Clin. Immunol. Immunopathol. 77, 291-297.
13. Griem, P., Gleichmann, E. (1995) Metal ion induced autoimmunity. Curr. Opin. Immunol. 7, 831-838.
14. Bagenstose, L. M., Salgame, P., Monestier, M. (1999) Cytokine regulation of a rodent model of mercuric chloride-induced autoimmunity. Environ. Health Perspect. 107, 807-810.
15. Hansson, M., Abedi-Valugerdi, M. (2003) Xenobiotic metal-induced autoimmunity: mercury and silver differentially induce antinucleolar autoantibody production in susceptible H-2s, H-2q and H-2f mice. Clin. Exp. Immunol. 131, 405-414.
16. Druet, P., Druet, E., Potdevin, F., Sapin, C. (1978) Immune type glomerulonephritis induced by HgCl2 in the Brown Norway rat. Ann. Immunol. (Paris) 129, 777-792.
17. Bariety, J., Druet, P., Laliberte, F., Sapin, C. (1971) Glomerulonephritis with - and 1C-globulin deposits induced in rats by mercuric chloride. Am. J. Pathol. 65, 293-302.
18. Sapin, C., Druet, E., Druet, P. (1977) Induction of anti-glomerular basement membrane antibodies in the Brown-Norway rat by mercuric chloride. Clin. Exp. Immunol. 28, 173-179.
19. Goldman, M., Druet, P., Gleichmann, E. (1991) TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol. Today 12, 223-227.
20. Mathieson, P. W., Thiru, S., Oliveira, D. B. (1992) Mercuric chloride-treated brown Norway rats develop widespread tissue injury including necrotizing vasculitis. Lab. Invest. 67, 121-129.
21. Moszczyński, P., Słowiński, S., Rutkowski, J., Bem, S., Jakus-Stoga, D. (1995) Lymphocytes, T and NK cells, in men occupationally exposed to mercury vapors. Int. J. Occup. Med. Environ. Health 8, 49-56.
22. Cardenas, A., Roels, H., Bernard, A. M., Barbon, R., Buchet, J. P., Lauwerys, R. R., Rosell, J., Hotter, G., Mutti, A., Franchini, I., Fels, L. M., Stolte, H., De Broe, M. E., Nuyts, G. D., Taylor, S. A., Price, R. G. (1993) Markers of early renal changes induced by industrial pollutants. I. Application to workers exposed to mercury vapor. Br. J. Ind. Med. 50, 17-27.
23. Aris, J. P., Blobel, G. (1991) cDNA cloning and sequencing of human fibrillarin, a conserved nucleolar protein recognized by autoimmune antisera. Proc. Natl. Acad. Sci. USA 88, 931-935.
24. Okano, Y., Steen, V. D., Medsger Jr., T. A. (1992) Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis. Arthritis Rheum. 35, 95-100.
25. Arnett, F. C., Fritzler, M. J., Ahn, C., Holian, A. (2000) Urinary mercury levels in patients with autoantibodies to U3-RNP (fibrillarin). J. Rheumatol. 27, 405-410.
26. Robinson, C. J., Balazs, T., Egorov, I. K. (1986) Mercuric chloride-, gold sodium thiomalate-, and D-penicillamine-induced antinuclear antibodies in mice. Toxicol. Appl. Pharmacol. 86, 159-169.
27. Schuhmann, D., Kubicka-Muranyi, M., Mirtschewa, J., Günther, J., Kind, P., Gleichmann, E. (1990) Adverse immune reactions to gold. I. Chronic treatment with an Au(I) drug sensitizes mouse T cells not to Au(I), but to Au(III) and induces autoantibody formation. J. Immunol. 145, 2132-2139.
28. Galli, S. J., Kalesnikoff, J., Grimbaldeston, M. A., Piliponsky, A. M., Williams, C. M., Tsai, M. (2005) Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23, 749-786.
29. Rottem, M., Mekori, Y. A. (2005) Mast cells and autoimmunity. Autoimmun. Rev. 4, 21-27.
30. Kiely, P. D., Thiru, S., Oliveira, D. B. (1995) Inflammatory polyarthritis induced by mercuric chloride in the Brown Norway rat. Lab. Invest. 73, 284-293.
31. Eneström, S., Hultman, P. (1995) Does amalgam affect the immune system? A controversial issue. Int. Arch. Allergy Immunol. 106, 180-203.
32. Kiely, P. D., Pecht, I., Oliveira, D. B. (1997) Mercuric chloride-induced vasculitis in the Brown Norway rat: αβ T cell-dependent and -independent phases: role of the mast cell. J. Immunol. 159, 5100 -5106.
33. + induces cell degranulation and mediator release. Biochem. Biophys. Res. Commun. 283, 707-714.
34. Savignac, M., Badou, A., Delmas, C., Subra, J. F., De Cramer, S., Paulet, P., Cassar, G., Druet, P., Saoudi, A., Pelletier, L. (2001) Gold is a T cell polyclonal activator in BN and LEW rats but favors IL-4 expression only in autoimmune prone BN rats. Eur. J. Immunol. 31, 2266-2276.
35. Suzuki, Y., Yoshimaru, T., Matsui, T., Ra, C. (2002) Silver activates calcium signals in rat basophilic leukemia-2H3 mast cells by a mechanism that differs from the FcεRI-activated response. J. Immunol. 169, 3954-3962.
36. 2+ influx. Free Radic. Biol. Med. 40, 1949-1959.
37. 2+ channels. Mol. Immunol. 46, 1267-1277.
38. Kojima, H., Nakatsubo, N., Kikuchi, K., Kawahara, S., Kirino, Y., Nagoshi, H., Hirata, Y., Nagano, T. (1998) Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal. Chem. 70, 2446-2453.
39. Suzuki, N., Kojima, H., Urano, Y., Kikuchi, K., Hirata, Y., Nagano, T. (2002) Orthogonality of calcium concentration and ability of 4,5-diaminofluorescein to detect NO. J. Biol. Chem. 277, 47-49.
40. Dedkova, E. N., Ji, X., Lipsius, S. L., Blatter, L. A. (2004) Mitochondrial calcium uptake stimulates nitric oxide production in mitochondria of bovine vascular endothelial cells. Am. J. Physiol. Cell Physiol. 286, C406-C415.
41. 2 production in mouse cerebral arteries. Cardiovasc. Res. 73, 73- 81.
42. Werner, E. R., Pitters, E., Schmidt, K., Wachter, H., Werner-Felmayer, G., Mayer, B. (1996) Identification of the 4-amino analogue of tetrahydrobiopterin as a dihydropteridine reductase inhibitor and a potent pteridine antagonist of rat neuronal nitric oxide synthase. Biochem. J. 320, 193-196.
43. Werner, E. R., Werner-Felmayer, G. (2002) Biopterin analogues: novel nitric oxide synthase inhibitors with immunosuppressive action. Curr. Drug Metab. 3, 119-121.
44. Thomas, D. D., Miranda, K. M., Colton, C. A., Citrin, D., Espey, M. G., Wink, D. A. (2003) Heme proteins and nitric oxide (NO): the neglected, eloquent chemistry in NO redox signaling and regulation. Antioxid. Redox Signal. 5, 307-317.
45. McCauley, S. D., Gilchrist, M., Befus, A. D. (2005) Nitric oxide: a major determinant of mast cell phenotype and function. Mem. Inst. Oswaldo Cruz 100 (Suppl. 1), 11-14.
46. Suzuki, Y., Yoshimaru, T., Inoue, T., Nunomura, S., Ra, C. (2008) The high-affinity immunoglobulin E receptor (FcεRI) regulates mitochondrial calcium uptake and a dihydropyridine receptor-mediated calcium influx in mast cells: role of the FcεRIβ chain immunoreceptor tyrosine-based activation motif. Biochem. Pharmacol. 75, 1492-1503.
47. Wills, F. L., Gilchrist, M., Befus, A. D. (1999) Interferon-γ regulates the interaction of RBL-2H3 cells with fibronectin through production of nitric oxide. Immunology 97, 481-489.
48. Forsythe, P., Befus, A. D. (2003) Inhibition of calpain is a component of nitric oxide-induced down-regulation of human mast cell adhesion. J. Immunol. 170, 287-293.
49. Kanwar, S., Wallace, J. L., Befus, D., Kubes, P. (1994) Nitric oxide synthesis inhibition increases epithelial permeability via mast cells. Am. J. Physiol. 266, G222-G229.
50. Zweier, J. L., Samouilov, A., Kuppusamy, P. (1999) Non-enzymatic nitric oxide synthesis in biological systems. Biochim. Biophys. Acta 1411, 250-262.
51. Lepore, D. A. (2000) Nitric oxide synthase-independent generation of nitric oxide in muscle ischemia-reperfusion injury. Nitric Oxide 4, 541-545.
52. Hogg, N. (2002) The biochemistry and physiology of S-nitrosothiols. Annu. Rev. Pharmacol. Toxicol. 42, 585-600.
53. 2+ channel protects mast cells against activation-induced cell death by preventing mitochondrial integrity disruption. Mol. Immunol. 46, 2370 -2380.
54. 2+-dependent mast cell death induced by Ag (I) via cardiolipin oxidation and ATP depletion. J. Leukoc. Biol. 86, 167-179.